168 related articles for article (PubMed ID: 10712355)
1. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study.
Matsui K; Takeda K; Yu ZX; Valencia J; Travis WD; Moss J; Ferrans VJ
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):1002-9. PubMed ID: 10712355
[TBL] [Abstract][Full Text] [Related]
2. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis.
Logginidou H; Ao X; Russo I; Henske EP
Chest; 2000 Jan; 117(1):25-30. PubMed ID: 10631194
[TBL] [Abstract][Full Text] [Related]
3. Expression of human telomerase reverse transcriptase in lymphangioleiomyomatosis.
Kumaki F; Takeda K; Yu ZX; Moss J; Ferrans VJ
Am J Respir Crit Care Med; 2002 Jul; 166(2):187-91. PubMed ID: 12119231
[TBL] [Abstract][Full Text] [Related]
4. Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis.
Matsui K; Takeda K; Yu ZX; Travis WD; Moss J; Ferrans VJ
Arch Pathol Lab Med; 2000 Feb; 124(2):267-75. PubMed ID: 10656737
[TBL] [Abstract][Full Text] [Related]
5. In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.
Gao L; Yue MM; Davis J; Hyjek E; Schuger L
Virchows Arch; 2014 Apr; 464(4):495-503. PubMed ID: 24570392
[TBL] [Abstract][Full Text] [Related]
6. Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features.
Ferrans VJ; Yu ZX; Nelson WK; Valencia JC; Tatsuguchi A; Avila NA; Riemenschn W; Matsui K; Travis WD; Moss J
J Nippon Med Sch; 2000 Oct; 67(5):311-29. PubMed ID: 11031360
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary lymphangioleiomyomatosis. Morphologic and immunohistochemical findings].
Kuhnen C; Preisler K; Müller KM
Pathologe; 2001 May; 22(3):197-204. PubMed ID: 11402850
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor expression in endometria from women treated with tamoxifen.
Kommoss F; Karck U; Prömpeler H; Pfisterer J; Kirkpatrick CJ
Gynecol Oncol; 1998 Aug; 70(2):188-91. PubMed ID: 9740688
[TBL] [Abstract][Full Text] [Related]
9. Assessment of response to tamoxifen among Iraqi patients with advanced breast cancer.
al-Alwan NA; al-Kubaisy W; al-Rawaq K
East Mediterr Health J; 2000; 6(2-3):475-82. PubMed ID: 11556039
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of proteins of the Bcl-2 family in pulmonary lymphangioleiomyomatosis: association of Bcl-2 expression with hormone receptor status.
Usuki J; Horiba K; Chu SC; Moss J; Ferrans VJ
Arch Pathol Lab Med; 1998 Oct; 122(10):895-902. PubMed ID: 9786350
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis.
Grzegorek I; Lenze D; Chabowski M; Janczak D; Szolkowska M; Langfort R; Szuba A; Dziegiel P
Anticancer Res; 2015 Jun; 35(6):3353-60. PubMed ID: 26026095
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen lowers the MMP-9/TIMP-1 ratio and inhibits the invasion capacity of ER-positive non-small cell lung cancer cells.
Wang XY; Wang Y; Liu HC
Biomed Pharmacother; 2011 Oct; 65(7):525-8. PubMed ID: 21993004
[TBL] [Abstract][Full Text] [Related]
13. [Pulmonary lymphangioleiomyomatosis].
Dvorakovskaia IV; Baranova OP
Arkh Patol; 2005; 67(5):29-32. PubMed ID: 16323477
[TBL] [Abstract][Full Text] [Related]
14. Matrix proteoglycans and remodelling of interstitial lung tissue in lymphangioleiomyomatosis.
Merrilees MJ; Hankin EJ; Black JL; Beaumont B
J Pathol; 2004 Jun; 203(2):653-60. PubMed ID: 15141380
[TBL] [Abstract][Full Text] [Related]
15. Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via matrix metalloproteinase-induced cell invasiveness.
Glassberg MK; Elliot SJ; Fritz J; Catanuto P; Potier M; Donahue R; Stetler-Stevenson W; Karl M
J Clin Endocrinol Metab; 2008 May; 93(5):1625-33. PubMed ID: 18285421
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of steroid receptors in a case of pulmonary lymphangioleiomyomatosis.
Colley MH; Geppert E; Franklin WA
Am J Surg Pathol; 1989 Sep; 13(9):803-7. PubMed ID: 2764227
[TBL] [Abstract][Full Text] [Related]
17. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial.
Hilsenbeck SG; Osborne CK
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1049s-1055s. PubMed ID: 16467123
[TBL] [Abstract][Full Text] [Related]
20. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
